USANA Health (USNA) delivered earnings and revenue surprises of 24.64% and 2.03%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Despite a Dip in Net Sales, EPS Exceeds Analyst Expectations
Health and wellness products company USANA Health Sciences (NYSE:USNA) reported results in line with analysts' expectations in Q1 CY2024, with revenue down 8.3% year on year to $227.8 million. On the other hand, the company's full-year revenue guidance of $885 million at the midpoint came in slightly below analysts' estimates. It made a GAAP profit of $0.86 per share, down from its profit of $0.95 per share in the same quarter last year.